Applied Therapeutics stock collapses as FDA rejects govorestat for galactosemia treatment

Shares of Applied Therapeutics, Inc. (Nasdaq: APLT) suffered a dramatic decline after the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) ... Read More